Serie de links interesantes.
Publicado: Dom Ene 02, 2011 6:12 pm
Hola a tod@s:
Annie nos aporta una serie de links interesantes.
Si queréis traducirlos, usad el traductor de Google:
http://translate.google.es/?hl=es&langp ... Translator#
Temas:
PDF.
The latest issue of Myeloma Today is on the web.
http://myeloma.org/pdfs/MT805_b5web_.pdf
Continuous Therapy in Multiple Myeloma – Media Workshop
http://event.on24.com/eventRegistration ... d=44161234
Download the Myeloma Manager™ Personal Care Assistant™
http://myeloma.org/ArticlePage.action?t ... 16&aTab=-1
Webcasts:The 52nd Annual Meeting of the American Society of Hematology took place in Orlando, Florida December 4-7, 2010. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma(para los que entienden el inglés hablado:cada vez mas , en vez de articulos, la infoirmacion se hace con videos.. En el intergroupe français du myelome,se presenta toda la informacion y testimonios, con video..Nada por escrito que se pueda traducir..la informacion se hace hablando, por videos.estos 4 videos son muy uinteresante:pero hay que entender el inglés.)
http://myeloma.org/IndexPage.action?tab ... goryId=449
luego estan todos estos articulos super top sobre MM, publicados en la revista BLOOD:
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Disruption of Src function potentiates Chk1 inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes
http://bloodjournal.hematologylibrary.o ... /5285?etoc
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
http://bloodjournal.hematologylibrary.o ... /5126?etoc
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
http://bloodjournal.hematologylibrary.o ... /4906?etoc
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
http://bloodjournal.hematologylibrary.o ... /4777?etoc
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
http://bloodjournal.hematologylibrary.o ... /4745?etoc
Improving the therapeutic index in myeloma
http://bloodjournal.hematologylibrary.o ... /4733?etoc
Pharmaceutical inhibition of glycogen-synthetase-kinase-3-beta reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Anticipation in familial hematological malignancies
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2-chemokines promoting myeloma cell migration
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor
http://bloodjournal.hematologylibrary.o ... /4560?etoc
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
http://bloodjournal.hematologylibrary.o ... /4045?etoc
ESTUDIOS CLINICOS:
A Phase 2 Study of AZD6244 in Multiple Myeloma
http://clinicaltrials.gov/ct2/show/NCT01085214
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
http://clinicaltrials.gov/ct2/show/NCT01109407
PX-171-009 – Phase III study comparing carfilzomib, lenalidomide, and dexamethasone (CRd) vs lenalidomide and dexamethasone (Rd) in subjects with relapsed multiple myeloma (US)
http://myeloma.org/ArticlePage.action?t ... PageId=188
Gracias fercu y mary
Annie nos aporta una serie de links interesantes.
Si queréis traducirlos, usad el traductor de Google:
http://translate.google.es/?hl=es&langp ... Translator#
Temas:
PDF.
The latest issue of Myeloma Today is on the web.
http://myeloma.org/pdfs/MT805_b5web_.pdf
Continuous Therapy in Multiple Myeloma – Media Workshop
http://event.on24.com/eventRegistration ... d=44161234
Download the Myeloma Manager™ Personal Care Assistant™
http://myeloma.org/ArticlePage.action?t ... 16&aTab=-1
Webcasts:The 52nd Annual Meeting of the American Society of Hematology took place in Orlando, Florida December 4-7, 2010. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma(para los que entienden el inglés hablado:cada vez mas , en vez de articulos, la infoirmacion se hace con videos.. En el intergroupe français du myelome,se presenta toda la informacion y testimonios, con video..Nada por escrito que se pueda traducir..la informacion se hace hablando, por videos.estos 4 videos son muy uinteresante:pero hay que entender el inglés.)
http://myeloma.org/IndexPage.action?tab ... goryId=449
luego estan todos estos articulos super top sobre MM, publicados en la revista BLOOD:
Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Disruption of Src function potentiates Chk1 inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes
http://bloodjournal.hematologylibrary.o ... /5285?etoc
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
http://bloodjournal.hematologylibrary.o ... /5126?etoc
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
http://bloodjournal.hematologylibrary.o ... /4906?etoc
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
http://bloodjournal.hematologylibrary.o ... /4777?etoc
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
http://bloodjournal.hematologylibrary.o ... /4745?etoc
Improving the therapeutic index in myeloma
http://bloodjournal.hematologylibrary.o ... /4733?etoc
Pharmaceutical inhibition of glycogen-synthetase-kinase-3-beta reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Anticipation in familial hematological malignancies
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Osteoclast-gene expression profiling reveals osteoclast-derived CCR2-chemokines promoting myeloma cell migration
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial
http://bloodjournal.hematologylibrary.o ... v1?papetoc
Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor
http://bloodjournal.hematologylibrary.o ... /4560?etoc
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
http://bloodjournal.hematologylibrary.o ... /4045?etoc
ESTUDIOS CLINICOS:
A Phase 2 Study of AZD6244 in Multiple Myeloma
http://clinicaltrials.gov/ct2/show/NCT01085214
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
http://clinicaltrials.gov/ct2/show/NCT01109407
PX-171-009 – Phase III study comparing carfilzomib, lenalidomide, and dexamethasone (CRd) vs lenalidomide and dexamethasone (Rd) in subjects with relapsed multiple myeloma (US)
http://myeloma.org/ArticlePage.action?t ... PageId=188
Gracias fercu y mary
